Amplifon stock rises to EUR 12.82 with EUR 2.8 billion market cap

Published on 10/09/2026 at 17:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Amplifon stock costs EUR 12.82 on October 9, 2026 after EUR 12.10. The P/E ratio is 42.4 and volume is 2,511,578 shares.

Key points in brief

Amplifon stock was trading at EUR 12.82 at Lang & Schwarz on October 9, 2026, up 5.95 percent from EUR 12.10.
The stock sits 19.07 percent below its EUR 15.84 52-week high.
Market capitalization was EUR 2.8 billion, with a P/E ratio of 42.4 and 2,511,578 shares traded.
Amplifon's next scheduled third-quarter report is October 29, 2026.

Extreme Makroaufnahme eines kleinen Hörgeräts mit sichtbaren technischen Details — Makroaufnahme eines Hörgeräts zeigt technisches Detail, thematisch passend zu Amplifon S.p.A., ISIN IT0004056880, Hörgerätehersteller, Illustration mit AI erstellt.

At EUR 12.82, Amplifon stock was trading at Lang & Schwarz on October 9, 2026 at 5:18 p.m. CEST, up 5.95 percent from the prior close of EUR 12.10. The move places the Italian hearing-care group below its 52-week high while keeping the stock above its yearly low.

Intraday quote reaches EUR 12.82

The Lang & Schwarz quote showed a bid of EUR 12.82 and an ask of EUR 12.83 at the same timestamp. Volume on Amplifon's primary listing was 2,511,578 shares as of October 9, 2026, versus an average volume of 1,511,985 shares.

The current quote is EUR 3.02 below the 52-week high of EUR 15.84 and EUR 4.98 above the low of EUR 7.84. Calculated against the high, the stock stood 19.07 percent lower; against the low, it was 63.52 percent higher.

Valuation carries a 42.4 P/E ratio

Amplifon's market capitalization was EUR 2.8 billion on October 9, 2026. The P/E ratio was 42.4 and the trailing dividend yield was 0.02 percent, placing valuation metrics alongside a sharp one-day advance.

Capital.com reported that first-half 2026 revenue reached EUR 1,185.7 million, up 1.30 percent at constant exchange rates. Adjusted EBITDA was EUR 298.0 million, up 3.60 percent year over year, while the adjusted EBITDA margin rose to 25.10 percent.

Comparison with peers

Amplifon: plus 5.95 percent, P/E 42.4, market capitalization EUR 2.8 billion
Sonova (SIX, CHF): plus 2.98 percent, P/E 35.7, market capitalization CHF 15.6 billion
Demant (Nasdaq Copenhagen, DKK): plus 6.16 percent, P/E 44.3, market capitalization DKK 72.0 billion

October 29 is the next date

Capital.com identifies October 29, 2026 as the next scheduled release date for Amplifon's third-quarter and nine-month report. The date gives the market a defined checkpoint for testing whether first-half growth and margin trends continued into the third quarter.

Price remains below the yearly high

Amplifon's primary listing is on Euronext Milan, where the company is part of the FTSE MIB. The comparison with Sonova and Demant shows that the October 9 move was positive across the selected hearing-care peers, while Amplifon's valuation remained between the two peer P/E ratios.

The further course of trading is shown by the continuously updated real-time quote of Amplifon stock.